Register for the recording of “ADHD: Assessment, diagnosis, medication, and psychotherapy options for ARNP”
Develop your clinical skills to more confidently diagnose and treat ADHD across the lifespan, using evidence-based and neurodiversity-affirming approaches at our Master Class, ADHD: Assessment, diagnosis, medication, and psychotherapy options for ARNPs.
Presenter Jessica Ross, PMHNP-BC, is a Psychiatric Nurse Practitioner with more than 12 years of experience working with neurodivergent families in private practice.
Her in-depth session, “Lessons in Neurodiversity: What I’ve learned about medicating ADHD,” will help you master your understanding of medications and how to use them for the effective management of ADHD across the lifespan.
We’ll explore common co-occurring medical conditions, such as PMDD; hEDS, P.O.T.S., and MCAS; menopause and andropause; narcolepsy; and binge eating disorder.
We’ll also discuss medical conditions that have similar symptoms, including TBI and epilepsy, ASD and sensory processing disorder, mood disorders, hypoglycemia, and sleep and hearing disorders.
Jessica’s practice includes providing care for both pediatric and adult patients with a special interest in neurodiverse conditions. She practices at Bridges Seattle, where she also precepts DNP candidates for the University of Washington, Seattle University, and John Hopkins.
Presenter Nyssa Petersen Ventura, PhD, is a Clinical Psychologist and Autism Center of Excellence provider with more than 10 years of experience in assessing ADHD, autism spectrum disorders, and other psychiatric conditions.
In her session, “Mastering ADHD Assessment Across the Lifespan: Tools and Strategies for Effective Diagnosis,” you’ll enhance your knowledge and skills to more confidently diagnose ADHD across the lifespan, using neurodiversity-affirming approaches.
You’ll gain insights into interpreting psychological testing reports and identify evidence-based assessment tools and strategies for recognizing ADHD in complex clinical populations.
Up to 5.0 ANCC contact hours, including 3.5 pharmacotherapeutic hours, will be available.